Hostname: page-component-78c5997874-s2hrs Total loading time: 0 Render date: 2024-11-10T11:06:13.009Z Has data issue: false hasContentIssue false
  • English
  • Français

Operable patent ductus arteriosus even with differential cyanosis: a case of patent ductus arteriosus and mitral stenosis

Published online by Cambridge University Press:  27 June 2017

Anunay Gupta  and
Shyam S. Kothari
Anunay Gupta
Affiliation:
Department of Cardiology, All India Institute of Medical Sciences, New Delhi, India
Shyam S. Kothari*
Affiliation:
Department of Cardiology, All India Institute of Medical Sciences, New Delhi, India
*
Correspondence to: Dr S. S. Kothari, Professor of Cardiology, All India Institute of Medical Sciences, New Delhi, 110029, India. Tel: 911126584419; Fax: +91 112 658 8663; E-mail: kothariss@vsnl.com
Get access Rights & Permissions [Opens in a new window]

Abstract

Patients with patent ductus arteriosus and significant left-to-right shunt develop Eisenmenger syndrome at an early age and are not operable after development of irreversible pulmonary artery hypertension. Patients with mitral stenosis, however, are treatable even with suprasystemic pulmonary artery pressures. A combination of these two lesions is rare. We document a patient with differential cyanosis who improved after corrective surgery of both the lesions. The importance of post-capillary pulmonary artery hypertension in shunt lesions needs to be better appreciated.

Keywords

Patent ductus arteriosusmitral stenosispulmonary artery hypertension
Type
Brief Report
Information
Cardiology in the Young , Volume 27 , Issue 9 , November 2017 , pp. 1845 - 1848
Check for updates
Copyright
© Cambridge University Press 2017 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Wood, P. The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt. Br Med J 1958; 2: 701–709.Google Scholar
2. Dalen, JE, Matloff, JM, Evans, GL, et al. Early reduction of pulmonary vascular resistance after mitral-valve replacement. N Engl J Med 1967; 277: 387–394.Google Scholar
3. Fawzy, ME, Hassan, W, Stefadouros, M, Moursi, M, El Shaer, F, Chaudhary, MA. Prevalence and fate of severe pulmonary hypertension in 559 consecutive patients with severe rheumatic mitral stenosis undergoing mitral balloon valvotomy. J Heart Valve Dis 2004; 13: 942–947.Google Scholar
4. Chopra, P, Bhatia, ML. Chronic rheumatic heart disease in India: a reappraisal of pathologic changes. J Heart Valve Dis 1992; 1: 92–101.Google Scholar
5. Dev, V, Shrivastava, S. Time course of changes in pulmonary vascular resistance and the mechanism of regression of pulmonary arterial hypertension after balloon mitral valvuloplasty. Am J Cardiol 1991; 67: 439–442.Google Scholar
6. Nair, KKM, Pillai, HS, Titus, T, et al. Persistent pulmonary artery hypertension in patients undergoing balloon mitral valvotomy. Pulm Circ 2013; 3: 426–431.Google Scholar
7. Dimopoulos, K, Wort, SJ, Gatzoulis, MA. Pulmonary hypertension related to congenital heart disease: a call for action. Eur Heart J 2014; 35: 691–700.Google Scholar
8. Mackinnon, J, Briggs, RM. Patent ductus arteriosus with mitral stenosis. Br Heart J 1958; 20: 424–426.Google Scholar
9. Talwar, S, Upadhyay, M, Ramakrishnan, S, Gharade, P, Choudhary, SK, Airan, B. Window-type patent ductus arteriosus with acquired rheumatic mitral stenosis. Congenit Heart Dis 2013; 8: E10–E12.Google Scholar
10. Kalantre, A, Sunil, GS, Kumar, RK. Pulmonary venous hypertension may allow delayed palliation of single ventricle physiology with pulmonary hypertension. Ann Pediatr Cardiol 2016; 9: 147–152.Google Scholar

Gupta and Kothari supplementary material

Gupta and Kothari supplementary material 1

Download Gupta and Kothari supplementary material(Video)
Video 9.2 MB